# MannKind to acquire V-Go insulin delivery device from Zealand Pharma

MannKind Corporation has agreed to acquire the V-Go wearable insulin delivery device from Zealand Pharma for $10 million plus sales-based milestones and inventory costs, expanding its diabetes portfolio.

- Type: Acquisition
- Announced: 2022-05-17
- Where: United States
- Value: $10.0M
- Status: announced
- Products: V-Go insulin delivery device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Zealand Pharma](https://endata.com/companies/45142.md) (target)
- [MannKind Corporation](https://endata.com/companies/62910.md) (acquirer)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2022/05/17/2444674/29517/en/mannkind-corporation-announces-agreement-to-acquire-v-go-insulin-delivery-device-from-zealand-pharma.html), 2022-05-17: "This acquisition strategically leverages our infrastructure in the diabetes space and positions MannKind's endocrine business for additional growth."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.